Conceptio › Archive › OpenCitations
OpenCitationsmetadata only

The Btk Inhibitor Ibrutinib (PCI-32765) In Combination With Rituximab Is Well Tolerated And Displays Profound Activity In High-Risk Chronic Lymphocytic Leukemia (CLL) Patients

Burger, Jan A. [omid:ra/062505485057]; Keating, Michael J. [omid:ra/062505485058]; Wierda, William G. [omid:ra/062505485059]; Hoellenriegel, Julia [omid:ra/062505485060]; Ferrajoli, Alessandra [omid:ra/062505485061]; Faderl, Stefan [omid:ra/062505485062]; Lerner, Susan [omid:ra/062505485063]; Zacharian, Gracy [omid:ra/062505485064]; Huang, Xuelin [omid:ra/062505485065]; James, Danelle F. [omid:ra/062505485066]; Buggy, Joseph J. [omid:ra/062505485067]; Kantarjian, Hagop M [omid:ra/062505485068]; O'Brien, Susan M. [omid:ra/062505485069]
OpenCitations · Papers · License: Open Access
Open Source ↗
citations, doi, seed:10.1186/1756-8722-6
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 19599
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.